ATYR — aTyr Pharma Balance Sheet
0.000.00%
- $75.99m
- -$13.38m
- $0.24m
Annual balance sheet for aTyr Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 31.7 | 108 | 66.1 | 98.2 | 72.1 |
| Net Total Receivables | 2.04 | 0.435 | 11.8 | 2.44 | 1.74 |
| Prepaid Expenses | |||||
| Total Current Assets | 35.5 | 114 | 80.9 | 103 | 82 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.98 | 1.81 | 11.6 | 14 | 11.9 |
| Other Long Term Assets | |||||
| Total Assets | 38.7 | 116 | 95.8 | 121 | 96.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 5.86 | 6.01 | 13.9 | 16.4 | 15 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.08 | 6.24 | 24.3 | 30 | 26.8 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 31.6 | 109 | 71.5 | 90.7 | 70 |
| Total Liabilities & Shareholders' Equity | 38.7 | 116 | 95.8 | 121 | 96.8 |
| Total Common Shares Outstanding |